{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:55:22Z","timestamp":1789152922248,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00468417"],"award-info":[{"award-number":["RS-2024-00468417"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.annonc.2026.05.700","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:39:20Z","timestamp":1779838760000},"page":"1293-1307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology"],"prefix":"10.1016","volume":"37","author":[{"given":"T.","family":"Cantore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-T.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.R.","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-3923","authenticated-orcid":false,"given":"A.","family":"Stemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-1992","authenticated-orcid":false,"given":"T.-G.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Dhruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Campagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3783-8590","authenticated-orcid":false,"given":"K.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-C.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Stemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-904X","authenticated-orcid":false,"given":"S.-J.","family":"Sammut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lipkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2847-4534","authenticated-orcid":false,"given":"M.","family":"Filipits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-1489","authenticated-orcid":false,"given":"C.","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.U.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ruppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annonc.2026.05.700_bib1","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2026.05.700_bib2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.annonc.2026.05.700_bib3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annonc.2026.05.700_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/tbcr-23-50","article-title":"Breast surgery after neoadjuvant systemic therapy","volume":"5","author":"Pawloski","year":"2024","journal-title":"Transl Breast Cancer Res"},{"key":"10.1016\/j.annonc.2026.05.700_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2026.05.700_bib6","series-title":"Breast Cancer","first-page":"31","article-title":"Subtypes of breast cancer","author":"Orrantia-Borunda","year":"2022"},{"key":"10.1016\/j.annonc.2026.05.700_bib7","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annonc.2026.05.700_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van \u2019t Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.annonc.2026.05.700_bib9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41591-019-0638-5","article-title":"Chromatin regulators mediate anthracycline sensitivity in breast cancer","volume":"25","author":"Seoane","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.annonc.2026.05.700_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s43018-021-00190-z","article-title":"Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response","volume":"2","author":"McNamara","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.annonc.2026.05.700_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13058-016-0728-y","article-title":"Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer","volume":"18","author":"Hu","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.annonc.2026.05.700_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/cancers14040881","article-title":"Development of gene expression-based random forest model for predicting neoadjuvant chemotherapy response in triple-negative breast cancer","volume":"14","author":"Park","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.annonc.2026.05.700_bib13","article-title":"Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.annonc.2026.05.700_bib14","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-20-2662","article-title":"Gene expression-based prediction of neoadjuvant chemotherapy response in early breast cancer: results of the prospective multicenter EXPRESSION trial","volume":"27","author":"Edlund","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annonc.2026.05.700_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s43018-025-00917-2","article-title":"Hallmarks of artificial intelligence contributions to precision oncology","volume":"6","author":"Chang","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.annonc.2026.05.700_bib16","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.annonc.2026.05.700_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/djz042","article-title":"HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade","volume":"112","author":"Prat","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.annonc.2026.05.700_bib18","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annonc.2026.05.700_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection","volume":"11","author":"Lehmann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.annonc.2026.05.700_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/0008-5472.CAN-22-2682","article-title":"Spatial transcriptomic analysis of a diverse patient cohort reveals a conserved architecture in triple-negative breast cancer","volume":"83","author":"Bassiouni","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.annonc.2026.05.700_bib21","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","article-title":"Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes","volume":"12","author":"Lehmann","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.annonc.2026.05.700_bib22","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.annonc.2026.05.700_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.trecan.2017.09.001","article-title":"Breast cancer: multiple subtypes within a tumor?","volume":"3","author":"Yeo","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.annonc.2026.05.700_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.omtn.2020.12.018","article-title":"Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks","volume":"23","author":"Zhou","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.annonc.2026.05.700_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.annonc.2026.05.700_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-21-0887","article-title":"Deconvolving clinically relevant cellular immune cross-talk from bulk gene expression using CODEFACS and LIRICS stratifies patients with melanoma to anti-PD-1 therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.annonc.2026.05.700_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41467-018-08023-x","article-title":"Bulk tissue cell type deconvolution with multi-subject single-cell expression reference","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.annonc.2026.05.700_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14348\/molcells.2023.2178","article-title":"A comprehensive overview of RNA deconvolution methods and their application","volume":"46","author":"Im","year":"2023","journal-title":"Mol Cells"},{"key":"10.1016\/j.annonc.2026.05.700_bib29","article-title":"A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response","volume":"5","author":"Xu","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.annonc.2026.05.700_bib30","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1158\/0008-5472.CAN-25-4350","article-title":"Path2Omics enhances transcriptomic and methylation prediction accuracy from tumor histopathology","volume":"85","author":"Hoang","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.annonc.2026.05.700_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.annonc.2026.05.700_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.annonc.2026.05.700_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-04278-5","article-title":"Multi-omic machine learning predictor of breast cancer therapy response","volume":"601","author":"Sammut","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.annonc.2026.05.700_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41698-023-00352-5","article-title":"Artificial intelligence reveals features associated with breast cancer neoadjuvant chemotherapy responses from multi-stain histopathologic images","volume":"7","author":"Huang","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.annonc.2026.05.700_bib35","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","article-title":"High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis","volume":"14","author":"Janesick","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.annonc.2026.05.700_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ctrv.2018.04.015","article-title":"Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer","volume":"67","author":"Cejalvo","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.annonc.2026.05.700_bib37","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1200\/JCO-25-01176","article-title":"Rethinking treatment priorities in estrogen receptor-low breast cancer","volume":"43","author":"Freeman","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annonc.2026.05.700_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101965","article-title":"HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: a systematic review and meta-analysis","volume":"84","author":"Schettini","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.annonc.2026.05.700_bib39","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1158\/1078-0432.CCR-13-0799","article-title":"Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes","volume":"19","author":"Masuda","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annonc.2026.05.700_bib40","article-title":"Path2Omics: enhanced transcriptomic and methylation prediction accuracy from tumor histopathology","author":"Hoang","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.annonc.2026.05.700_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK-25-473462","article-title":"Multimodal DE-escalation strategies in early breast cancer","volume":"45","author":"Meattini","year":"2025","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.annonc.2026.05.700_bib42","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annonc.2026.05.700_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1200\/OP.22.00483","article-title":"Role of immunotherapy in breast cancer","volume":"19","author":"Jacob","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.annonc.2026.05.700_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41523-021-00216-w","article-title":"Development and validation for research assessment of Oncotype DX\u00ae Breast Recurrence Score, EndoPredict\u00ae and Prosigna\u00ae","volume":"7","author":"Buus","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.annonc.2026.05.700_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104320","article-title":"HER2DX genomic test in HER2-positive\/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: a correlative analysis from the PerELISA trial","volume":"85","author":"Guarneri","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.annonc.2026.05.700_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103801","article-title":"Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer","volume":"75","author":"Prat","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.annonc.2026.05.700_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.annonc.2024.10.012","article-title":"TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy","volume":"36","author":"Mart\u00edn","year":"2025","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753426008847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753426008847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:49:14Z","timestamp":1787428154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753426008847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0923753426008847"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2026.05.700","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2026.05.700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}